Previous Article | Next Article 
Journal of Virology, October 2002, p. 10427-10436, Vol. 76, No. 20
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.20.10427-10436.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression
Kara L. Carter,
Ellen Cahir-McFarland, and Elliott Kieff*
Departments of Medicine and Microbiology and Molecular Genetics, Harvard Medical School, and The Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115
Received 14 February 2002/
Accepted 15 July 2002
To elucidate the mechanisms by which Epstein-Barr virus (EBV) latency III gene expression transforms primary B lymphocytes to lymphoblastoid cell lines (LCLs), the associated alterations in cell gene expression were assessed by using 4,146 cellular cDNAs arrayed on nitrocellulose filters and real-time reverse transcription-PCR (RT-PCR). A total of 1,405 of the 4,146 cDNAs were detected using cDNA probes from poly(A)+ RNA of IB4 LCLs, a non-EBV-infected Burkitt's lymphoma (BL) cell line, BL41, or EBV latency III-converted BL41 cells (BL41EBV). Thirty-eight RNAs were consistently twofold more abundant in the IB4 LCL and BL41EBV than in BL41 by microarray analysis. Ten of these are known to be EBV induced. A total of 23 of 28 newly identified EBV-induced genes were confirmed by real-time RT-PCR. In addition, nine newly identified genes and CD10 were EBV repressed. These EBV-regulated genes encode proteins involved in signal transduction, transcription, protein biosynthesis and degradation, and cell motility, shape, or adhesion. Seven of seven newly identified EBV-induced RNAs were more abundant in newly established LCLs than in resting B lymphocytes. Surveys of eight promoters of newly identified genes implicate NF-
B or PU.1 as potentially important mediators of EBV-induced effects through LMP1 or EBNA2, respectively. Thus, examination of the transcriptional effects of EBV infection can elucidate the molecular mechanisms by which EBV latency III alters B lymphocytes.
* Corresponding author. Mailing address: The Channing Laboratory, Brigham and Women's Hospital, 181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-4252. Fax: (617) 525-4257. E-mail:
ekieff{at}rics.bwh.harvard.edu.
Present address: Praecis Pharmaceuticals Incorporated, Waltham, MA 02451.
Journal of Virology, October 2002, p. 10427-10436, Vol. 76, No. 20
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.20.10427-10436.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bullaughey, K., Chavarria, C. I., Coop, G., Gilad, Y.
(2009). Expression quantitative trait loci detected in cell lines are often present in primary tissues. Hum Mol Genet
18: 4296-4303
[Abstract]
[Full Text]
-
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., Seto, M.
(2009). TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood
114: 2467-2475
[Abstract]
[Full Text]
-
Zhang, W., Zeng, Z., Zhou, Y., Xiong, W., Fan, S., Xiao, L., Huang, D., Li, Z., Li, D., Wu, M., Li, X., Shen, S., Wang, R., Cao, L., Tang, K., Li, G.
(2009). Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin
41: 414-428
[Abstract]
[Full Text]
-
Klibi, J., Niki, T., Riedel, A., Pioche-Durieu, C., Souquere, S., Rubinstein, E., Le Moulec, S., Guigay, J., Hirashima, M., Guemira, F., Adhikary, D., Mautner, J., Busson, P.
(2009). Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood
113: 1957-1966
[Abstract]
[Full Text]
-
Xu, D., Zhao, L., Del Valle, L., Miklossy, J., Zhang, L.
(2008). Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes. J. Virol.
82: 6251-6258
[Abstract]
[Full Text]
-
Xing, L., Kieff, E.
(2007). Epstein-Barr Virus BHRF1 Micro- and Stable RNAs during Latency III and after Induction of Replication. J. Virol.
81: 9967-9975
[Abstract]
[Full Text]
-
Pegtel, D. M., Subramanian, A., Meritt, D., Tsai, C.-H., Sheen, T.-S., Golub, T. R., Thorley-Lawson, D. A.
(2007). IFN-{alpha}-Stimulated Genes and Epstein-Barr Virus Gene Expression Distinguish WHO Type II and III Nasopharyngeal Carcinomas. Cancer Res.
67: 474-481
[Abstract]
[Full Text]
-
Dinarello, C A, Kim, S-H
(2006). IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis
65: iii61-iii64
[Abstract]
[Full Text]
-
Maier, S., Staffler, G., Hartmann, A., Hock, J., Henning, K., Grabusic, K., Mailhammer, R., Hoffmann, R., Wilmanns, M., Lang, R., Mages, J., Kempkes, B.
(2006). Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2. J. Virol.
80: 9761-9771
[Abstract]
[Full Text]
-
Xu, D., Brumm, K., Zhang, L.
(2006). The Latent Membrane Protein 1 of Epstein-Barr Virus (EBV) Primes EBV Latency Cells for Type I Interferon Production. J. Biol. Chem.
281: 9163-9169
[Abstract]
[Full Text]
-
Zhao, B., Maruo, S., Cooper, A., R. Chase, M., Johannsen, E., Kieff, E., Cahir-McFarland, E.
(2006). RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA
103: 1900-1905
[Abstract]
[Full Text]
-
Goda, C., Kanaji, T., Kanaji, S., Tanaka, G., Arima, K., Ohno, S., Izuhara, K.
(2006). Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol
18: 233-240
[Abstract]
[Full Text]
-
Lua, D. T., Yasuike, M., Hirono, I., Aoki, T.
(2005). Transcription Program of Red Sea Bream Iridovirus as Revealed by DNA Microarrays. J. Virol.
79: 15151-15164
[Abstract]
[Full Text]
-
Zhang, J., Wang, J., Wood, C., Xu, D., Zhang, L.
(2005). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Replication and Transcription Activator Regulates Viral and Cellular Genes via Interferon-Stimulated Response Elements. J. Virol.
79: 5640-5652
[Abstract]
[Full Text]
-
Najjar, I., Baran-Marszak, F., Le Clorennec, C., Laguillier, C., Schischmanoff, O., Youlyouz-Marfak, I., Schlee, M., Bornkamm, G. W., Raphael, M., Feuillard, J., Fagard, R.
(2005). Latent Membrane Protein 1 Regulates STAT1 through NF-{kappa}B-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells. J. Virol.
79: 4936-4943
[Abstract]
[Full Text]
-
Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K., Zhang, L.
(2004). The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes. J. Biol. Chem.
279: 46335-46342
[Abstract]
[Full Text]
-
Rieger, K. E., Chu, G.
(2004). Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res
32: 4786-4803
[Abstract]
[Full Text]
-
Cahir-McFarland, E. D., Carter, K., Rosenwald, A., Giltnane, J. M., Henrickson, S. E., Staudt, L. M., Kieff, E.
(2004). Role of NF-{kappa}B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells. J. Virol.
78: 4108-4119
[Abstract]
[Full Text]
-
DeBiasi, R. L., Clarke, P., Meintzer, S., Jotte, R., Kleinschmidt-Demasters, B. K., Johnson, G. L., Tyler, K. L.
(2003). Reovirus-Induced Alteration in Expression of Apoptosis and DNA Repair Genes with Potential Roles in Viral Pathogenesis. J. Virol.
77: 8934-8947
[Abstract]
[Full Text]